KC
Kali Charan Jaiswal
About Kali Charan Jaiswal
Data last updated:
Kali Charan Jaiswal is a Director at Human Biolife India Private Limited (since 2014), Director at Nexwin Pharma Private Limited (since 2020) and Director at Bioxtreme Pharma Private Limited (since 2021), and holds 1 more current directorship. The companies operate in Pharma and Healthcare. The 3 current companies with reported revenue have a combined latest revenue of ₹28.65 Cr; the largest is Human Biolife India Private Limited at ₹21.15 Cr (FY 2023). Earlier, Kali Charan Jaiswal was a Director at Sanovia Biotech Private Limited (2016–2017).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Human Biolife India Private Limited U24233UP2014PTC067770 | Director | 23 Dec 2014 | 2014 | ₹21.15 Cr (FY 2023) | Active |
 Nexwin Pharma Private Limited U24239HR2020PTC088818 | Director | 31 Aug 2020 | 2020 | ₹4.89 Cr (FY 2024) | Active |
| Bioxtreme Pharma Private Limited U24230HR2021PTC094502 | Director | 15 Apr 2021 | 2021 | ₹2.62 Cr (FY 2025) | Active |
| Sparkbless Pharma Private Limited U24290HR2021PTC098635 | Director | 22 Oct 2021 | 2021 | Active |
Previous companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Sanovia Biotech Private Limited U24304HR2016PTC066063 | Director | 10 Oct 2016 | 2016 | ₹1.68 Cr (FY 2025) | Active |
Explore Director's current and past company associations Uncover their professional journey today!
Board colleagues of Kali Charan Jaiswal
| Name | DIN | Company | Designation |
|---|---|---|---|
| Jyoti Jaiswal | 07043500 | Human Biolife India Private Limited , Nexwin Pharma Private Limited and 1 more | Managing Director |
| Avadhesh Kumar Singh | 09147587 | Bioxtreme Pharma Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Kali Charan Jaiswal
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Kali Charan Jaiswal
Kali Charan Jaiswal currently holds 4 directorships: Human Biolife India Private Limited (Director, since 23 Dec 2014, revenue ₹21.15 Cr (FY 2023)); Nexwin Pharma Private Limited (Director, since 31 Aug 2020, revenue ₹4.89 Cr (FY 2024)); Bioxtreme Pharma Private Limited (Director, since 15 Apr 2021, revenue ₹2.62 Cr (FY 2025)); Sparkbless Pharma Private Limited (Director, since 22 Oct 2021).
Kali Charan Jaiswal was first appointed on 23 Dec 2014 as Director at Human Biolife India Private Limited. The most recent appointment on record is 22 Oct 2021 at Sparkbless Pharma Private Limited.
The 3 current companies of Kali Charan Jaiswal that report revenue have a combined latest revenue of ₹28.65 Cr: Human Biolife India Private Limited ₹21.15 Cr (FY 2023); Nexwin Pharma Private Limited ₹4.89 Cr (FY 2024); Bioxtreme Pharma Private Limited ₹2.62 Cr (FY 2025).
Kali Charan Jaiswal held 1 earlier board appointment: Sanovia Biotech Private Limited (Director, 10 Oct 2016 to 01 Sep 2017).
The current boards of Kali Charan Jaiswal's companies include Jyoti Jaiswal (Human Biolife India Private Limited), Avadhesh Kumar Singh (Bioxtreme Pharma Private Limited).